Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now later-stage tilt small index

Inflammatory Markers: later-stage trial registry

4 of 4 indexed Inflammatory Markers trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 4 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Inflammatory Markers: 4 US clinical trials tracked, 4 recruiting.

Inflammatory Markers is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Virginia Polytechnic Institute and State University, running 2 of these trials.

Enrollment posture brief

Registry condition inflammatory-markers

OPEN 4 | RECR 100% | LATE 1 | EARLY 0 | RANK #4115 | SPON 2

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Inflammatory Markers (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Inflammatory Markers

Inflammatory Markers lists 4 open slots (100% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Inflammatory Markers on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Inflammatory Markers is recruiting above its size-band peers.

    4 of 4 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Inflammatory Markers records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Non-Nutritive Sweetener Intake and impact on glucose homeostasis Other
2 trials
Colchicine (Colcrys®) Drug
1 trials
Infant walnut intake Other
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Inflammatory Markers trials. A trial with sites in several states counts in each.

Virginia 2 trials
Kentucky 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Inflammatory Markers page

4 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Inflammatory Markers condition card totals 4 registered trials; most-linked intervention Non-Nutritive Sweetener Intake and impact on glucose homeostasis; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.